Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Gnant, M; Pfeiler, G; Steger, GG; Egle, D; Greil, R; Fitzal, F; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Bjelic-Radisic, V; Jakesz, R; Marth, C; Sevelda, P; Mlineritsch, B; Exner, R; Fesl, C; Frantal, S; Singer, CF LANCET ONCOL. 2019; 20(3): 339-351.

Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic Therapy.

Woll, E; Eisterer, W; Gerger, A; Kuhr, T; Prager, GW; Rumpold, H; Ulrich-Pur, H; Vogl, U; Winder, T; Weiss, L; Greil, R ANTICANCER RES. 2019; 39(9): 4589-4596.

Lignans and sesquiterpene lactones from Hypochaeris radicata subsp. neapolitana (Asteraceae, Cichorieae).

Shulha, O; Cicek, SS; Wangensteen, H; Kroes, J; Mader, M; Girreser, U; Sendker, J; Johrer, K; Greil, R; Schuhly, W; Mangoni, A; Grauso, L; van Thriel, C; Zidorn, C PHYTOCHEMISTRY. 2019; 165: 112047

Systemic treatment of metastatic breast cancer: SABCS 2018

Westphal, T; Gampenrieder, SP; Greil, R MEMO-MAG EUR MED ONC. 2019; 12(3): 253-256.

Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group

Fuchs, M; Goergen, H; Kobe, C; Kuhnert, G; Lohri, A; Greil, R; Sasse, S; Topp, MS; Schafer, E; Hertenstein, B; Soekler, M; Vogelhuber, M; Zijlstra, JM; Keller, UB; Krause, SW; Wilhelm, M; Maschmeyer, G; Thiemer, J; Duhrsen, U; Meissner, J; Viardot, A; Eich, H; Baues, C; Diehl, V; Rosenwald, A; von Tresckow, B; Dietlein, M; Borchmann, P; Engert, A J CLIN ONCOL. 2019; 37(31): 2835-+.

Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia

Willenbacher, E; Johrer, K; Willenbacher, W; Flogel, B; Greil, R; Kircher, B ANN HEMATOL. 2019;

C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients.

Schlick, K; Magnes, T; Huemer, F; Ratzinger, L; Weiss, L; Pichler, M; Melchardt, T; Greil, R; Egle, A; J Clin Med. 2019; 8(11):

Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria A cross-sectional multicentre observational study

Balic, M; Hilbe, W; Gusel, S; Fiegl, M; Ludwig, H; Mayrbaurl, B; Thaler, J; Samonigg, H; Hegenbarth, K; Eisner, F; Mlineritsch, B; Greil, R; Schandl, MJ; Weltermann, A; Petzer, A; Fuchs, D; Stangl, W; Krippl, P; Stauder, R; Stoger, H MEMO-MAG EUR MED ONC. 2019;

B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.

Asslaber, D; Qi, Y; Maeding, N; Steiner, M; Denk, U; Hopner, JP; Hartmann, TN; Zaborsky, N; Greil, R; Egle, A BLOOD. 2019; 134(20): 1717-1729.

Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

Thieblemont, C; Howlett, S; Casasnovas, RO; Mounier, N; Perrot, A; Morschhauser, F; Fruchart, C; Daguindau, N; van Eygen, K; Oberic, L; Bouabdallah, R; Pica, GM; Nicolas-Virezelier, E; Abraham, J; Fitoussi, O; Snauwaert, S; Eisenmann, JC; Lionne-Huyghe, P; Bron, D; Tricot, S; Deeren, D; Gonzalez, H; Costello, R; Le Du, K; da Silva, MG; Grosicki, S; Trotman, J; Catalano, J; Caballero, D; Greil, R; Cohen, AM; Gaulard, P; Roulin, L; Takeshita, K; Casadebaig, ML; Tilly, H; Coiffier, B BRIT J HAEMATOL. 2019;